299 related articles for article (PubMed ID: 25673725)
21. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
22. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
[TBL] [Abstract][Full Text] [Related]
23. Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy.
Cao L; Chen J; Wang Y; Yang Y; Qing J; Rao Z; Chen X; Lou Z
Protein Cell; 2019 Mar; 10(3):178-195. PubMed ID: 29542010
[TBL] [Abstract][Full Text] [Related]
24. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.
Evans MJ; von Hahn T; Tscherne DM; Syder AJ; Panis M; Wölk B; Hatziioannou T; McKeating JA; Bieniasz PD; Rice CM
Nature; 2007 Apr; 446(7137):801-5. PubMed ID: 17325668
[TBL] [Abstract][Full Text] [Related]
25. [Anti-hepatitis C virus strategy targeting host entry factor claudin-1].
Fukasawa M
Uirusu; 2015; 65(2):245-254. PubMed ID: 27760923
[TBL] [Abstract][Full Text] [Related]
26. Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.
Xiao F; Fofana I; Thumann C; Mailly L; Alles R; Robinet E; Meyer N; Schaeffer M; Habersetzer F; Doffoël M; Leyssen P; Neyts J; Zeisel MB; Baumert TF
Gut; 2015 Mar; 64(3):483-94. PubMed ID: 24848265
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
[TBL] [Abstract][Full Text] [Related]
28. Characterisation of endogenous Claudin-1 expression, motility and susceptibility to hepatitis C virus in CRISPR knock-in cells.
Clément CMH; Deffieu MS; Dorobantu CM; Baumert TF; Ayala-Nunez NV; Mély Y; Ronde P; Gaudin R
Biol Cell; 2020 May; 112(5):140-151. PubMed ID: 32034780
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition.
Li Q; Sodroski C; Lowey B; Schweitzer CJ; Cha H; Zhang F; Liang TJ
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7620-5. PubMed ID: 27298373
[TBL] [Abstract][Full Text] [Related]
30. Human-rat chimeric anti-occludin monoclonal antibodies inhibit hepatitis C virus infection.
Shimizu Y; Yoneda K; Shirasago Y; Suzuki T; Tada M; Ishii-Watabe A; Sugiyama K; Suzuki T; Wakita T; Yagi K; Kondoh M; Fukasawa M
Biochem Biophys Res Commun; 2019 Jun; 514(3):785-790. PubMed ID: 31079928
[TBL] [Abstract][Full Text] [Related]
31. Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro.
Tabll AA; Moustafa RI; El Abd YS; Bader El Din NG; El-Shenawy R; Yousef H; Hussein M; Dawood RM; Omran MH; El-Awady MK
J Immunoassay Immunochem; 2014; 35(1):60-73. PubMed ID: 24063617
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies against Hepatitis C genotype 3a virus like particle inhibit virus entry in cell culture system.
Das S; Shetty RK; Kumar A; Shridharan RN; Tatineni R; Chi G; Mukherjee A; Das S; Subbarao SM; Karande AA
PLoS One; 2013; 8(1):e53619. PubMed ID: 23341957
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
34. Viral kinetics suggests a reconciliation of the disparate observations of the modulation of claudin-1 expression on cells exposed to hepatitis C virus.
Padmanabhan P; Dixit NM
PLoS One; 2012; 7(4):e36107. PubMed ID: 22545157
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus entry is impaired by claudin-1 downregulation in diacylglycerol acyltransferase-1-deficient cells.
Sung PS; Murayama A; Kang W; Kim MS; Yoon SK; Fukasawa M; Kondoh M; Kim JS; Kim H; Kato T; Shin EC
J Virol; 2014 Aug; 88(16):9233-44. PubMed ID: 24899196
[TBL] [Abstract][Full Text] [Related]
36. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis C virus entry: role of host and viral factors.
Samreen B; Khaliq S; Ashfaq UA; Khan M; Afzal N; Shahzad MA; Riaz S; Jahan S
Infect Genet Evol; 2012 Dec; 12(8):1699-709. PubMed ID: 22878095
[TBL] [Abstract][Full Text] [Related]
38. Functional analysis of claudin-6 and claudin-9 as entry factors for hepatitis C virus infection of human hepatocytes by using monoclonal antibodies.
Fofana I; Zona L; Thumann C; Heydmann L; Durand SC; Lupberger J; Blum HE; Pessaux P; Gondeau C; Reynolds GM; McKeating JA; Grunert F; Thompson J; Zeisel MB; Baumert TF
J Virol; 2013 Sep; 87(18):10405-10. PubMed ID: 23864633
[TBL] [Abstract][Full Text] [Related]
39. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
[TBL] [Abstract][Full Text] [Related]
40. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
